Grand Pharmaceutical Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG210A71016
HKD
5.49
0.03 (0.55%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
12,283.27
11,644.89
10,529.59
9,562.28
8,597.98
6,352.92
6,590.64
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
12,283.27
11,644.89
10,529.59
9,562.28
8,597.98
6,352.92
6,590.64
Raw Material Cost
5,502.91
4,906.58
4,005.52
3,610.81
3,350.74
2,317.72
2,557.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,200.85
2,062.37
1,513.22
1,463.63
1,347.25
987.51
969.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
162.34
180.24
205.15
137.49
92.96
115.42
146.50
Selling and Distribution Expenses
4,731.81
4,107.49
3,288.68
2,901.93
2,897.24
2,306.61
2,680.71
Other Expenses
-186.03
-165.45
-114.64
-106.92
-110.88
-88.36
-92.96
Total Expenditure (Excl Depreciation)
10,737.61
9,602.21
7,866.19
7,044.66
6,579.40
4,843.65
5,424.41
Operating Profit (PBDIT) excl Other Income
1545.6999999999998
2042.7
2663.3999999999996
2517.6
2018.6000000000001
1509.3000000000002
1166.2
Other Income
359.13
237.36
219.37
222.09
279.72
314.14
233.43
Operating Profit (PBDIT)
2,492.15
2,783.78
3,274.98
3,134.63
2,637.82
2,110.47
1,876.78
Interest
162.34
180.24
205.15
137.49
92.96
115.42
146.50
Exceptional Items
-329.90
603.85
-308.42
-41.55
466.64
303.61
-12.13
Gross Profit (PBDT)
6,780.36
6,738.32
6,524.07
5,951.48
5,247.24
4,035.19
4,033.06
Depreciation
581.89
503.75
392.21
394.91
339.52
287.06
477.14
Profit Before Tax
1,418.02
2,703.64
2,369.20
2,560.68
2,671.97
2,011.60
1,241.01
Tax
249.78
386.30
448.75
418.64
380.80
292.37
230.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,240.87
2,468.38
1,880.00
2,079.42
2,402.56
1,792.66
1,150.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,240.87
2,468.38
1,880.00
2,079.42
2,402.56
1,792.66
1,150.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.43
-2.32
15.44
18.83
2.47
-11.45
-25.46
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,244.30
2,466.06
1,895.44
2,098.25
2,405.03
1,781.21
1,125.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
17,017.04
16,473.21
15,157.72
14,140.34
13,392.63
11,239.50
8,375.27
Earnings per share (EPS)
0.35
0.7
0.54
0.59
0.68
0.52
0.34
Diluted Earnings per share
0.35
0.7
0.54
0.59
0.68
0.52
0.34
Operating Profit Margin (Excl OI)
12.63%
17.54%
25.29%
26.33%
23.48%
23.76%
17.7%
Gross Profit Margin
16.28%
27.54%
26.23%
30.91%
35.03%
36.18%
26.07%
PAT Margin
10.1%
21.2%
17.85%
21.75%
27.94%
28.22%
17.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 5.48% vs 10.59% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -49.54% vs 30.11% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -16.23% vs -16.66% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -9.93% vs -12.14% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Grand Pharmaceutical Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
12,283.27
8,384.90
3,898.37
46.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
12,283.27
8,384.90
3,898.37
46.49%
Raw Material Cost
5,502.91
1,541.71
3,961.20
256.94%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
2,200.85
2,533.31
-332.46
-13.12%
Power Cost
0
0
0.00
Manufacturing Expenses
162.34
103.90
58.44
56.25%
Selling and Distribution Expenses
4,731.81
3,807.60
924.21
24.27%
Other Expenses
-186.03
-94.21
-91.82
-97.46%
Total Expenditure (Excl Depreciation)
10,737.61
7,044.44
3,693.17
52.43%
Operating Profit (PBDIT) excl Other Income
1,545.66
1,340.45
205.21
15.31%
Other Income
359.13
429.68
-70.55
-16.42%
Operating Profit (PBDIT)
2,492.15
2,183.16
308.99
14.15%
Interest
162.34
103.90
58.44
56.25%
Exceptional Items
-329.90
-22.70
-307.20
-1,353.30%
Gross Profit (PBDT)
6,780.36
6,843.19
-62.83
-0.92%
Depreciation
581.89
413.02
168.87
40.89%
Profit Before Tax
1,418.02
1,643.53
-225.51
-13.72%
Tax
249.78
184.72
65.06
35.22%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,240.87
1,457.61
-216.74
-14.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,240.87
1,457.61
-216.74
-14.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
3.43
0.00
3.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,244.30
1,457.61
-213.31
-14.63%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
17,017.04
10,478.61
6,538.43
62.40%
Earnings per share (EPS)
0.35
0.59
-0.24
-40.68%
Diluted Earnings per share
0.35
0.59
-0.24
-40.68%
Operating Profit Margin (Excl OI)
12.63%
15.99%
0.00
-3.36%
Gross Profit Margin
16.28%
24.53%
0.00
-8.25%
PAT Margin
10.10%
17.38%
0.00
-7.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,228.33 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 5.48% vs 10.59% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 124.43 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -49.54% vs 30.11% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 213.30 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -16.23% vs -16.66% in Dec 2024

Annual - Interest
Interest 16.23 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -9.93% vs -12.14% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.63%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024